Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
publishDate:"[2020 TO 2020]"
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"Phase: Phase 2"
topic_facet:"Recruitment Status: Not yet recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (44)
1
A Phase 2, Open-Label, Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19 : A Phase 2, Open-Label, Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19 - CALAVI
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
2
A Phase 2, Open-Label, Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19 : A Phase 2, Open-Label, Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19 - CALAVI
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
3
Corticoïdes au cours de la pneumonie virale Covid-19 liée à l’infection par le SARS-Cov-2 : Corticoïdes au cours de la pneumonie virale Covid-19 liée à l’infection par le SARS-Cov-2 - CORTI-Covid
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
4
Corticoïdes au cours de la pneumonie virale Covid-19 liée à l’infection par le SARS-Cov-2 : Corticoïdes au cours de la pneumonie virale Covid-19 liée à l’infection par le SARS-Cov-2 - CORTI-Covid
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
5
Hydroxychloroquine for the treatment of mild COVID-19 disease : Hydroxychloroquine for the treatment of mild COVID-19 disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
6
Hydroxychloroquine for the treatment of mild COVID-19 disease : Hydroxychloroquine for the treatment of mild COVID-19 disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
7
Anti-il6 treatment of serious COVID-19 disease with threatening respiratory failure : Effectiveness of Interleukin-6 Receptor Inhibitors in the Management of Patients with Severe SARS-CoV-2 Pneumonia: An Open-Label Multicenter Sequential Randomized Controlled Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
8
Anti-il6 treatment of serious COVID-19 disease with threatening respiratory failure : Effectiveness of Interleukin-6 Receptor Inhibitors in the Management of Patients with Severe SARS-CoV-2 Pneumonia: An Open-Label Multicenter Sequential Randomized Controlled Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
9
Sarilumab COVID-19 : An adaptive phase 2/3, randomized, double-blind, placebo-controlled, study assessing efficacy and safety of sarilumab for hospitalized patients with COVID19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
10
Sarilumab COVID-19 : An adaptive phase 2/3, randomized, double-blind, placebo-controlled, study assessing efficacy and safety of sarilumab for hospitalized patients with COVID19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Erscheinungsjahr: 2020-2020
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Medienart
44
Aufsätze
44
E-Artikel
44
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
44
610
Phase: Phase 2
Recruitment Status: Not yet recruiting
44
Study Type: Interventional
6
Medical Condition: Coronavirus infection MedDRA...
4
Medical Condition: Coronavirus infection MedDRA...
4
Medical Condition: Severe COVID-19 pneumonia Me...
2
Medical Condition: ;Certain infectious and para...
2
Medical Condition: Acute coronavirus disease 20...
2
Medical Condition: COVID-19 MedDRA version: 20....
2
Medical Condition: COVID19;Therapeutic area: Di...
2
Medical Condition: Corona virus infection MedDR...
2
Medical Condition: Hospitalized patients with s...
2
Medical Condition: SAR COV2 virus infection, wi...
2
Medical Condition: SARS-CoV-2 infection MedDRA ...
2
Medical Condition: Severe COVID-19 Infection Me...
2
Medical Condition: Severe COVID-19 Infection Me...
2
Medical Condition: Severe COVID-19 pneumonia Me...
2
Medical Condition: Subjects with life-threateni...
2
Medical Condition: This trial will investigate ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
40
Englisch
4
Unbestimmt
Haven't found what you're looking for?
Wird geladen...